Author:
Lehtinen Matti,Herrero Rolando,Mayaud Philippe,Barnabas Ruanne,Dillner Joakim,Paavonen Jorma,Smith Peter G.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference30 articles.
1. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial;Harper;Lancet,2004
2. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial;Villa;Lancet Oncol,2005
3. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis;Myers;Am J Epidemiol,2000
4. Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacy;Lehtinen;Int J STD AIDS,2006
5. Lehtinen M, Apter D, Dubin G, Patama T, Palmroth J, Laukkanen P, et al. Enrollment of 22,000 adolescent women to cancer registry follow-up of long-term human papillomavirus vaccine efficacy. Int J STD AIDS, in press.